SEC FORM 4
$7,640,825.75
BeOne Medicines Ltd. (ONC)
Sale of 21,254 shares at $359.5006 per share.
Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →